Innovation

GREENWOOD VILLAGE, Colo. & NEW YORK (BUSINESS WIRE) - ANANDA Scientific Inc., a biotech pharma company, and NYU Grossman School of Medicine today announced a second clinical trial to evaluate the effect of cannabidiol in ANANDA’s proprietary delivery technology on opioid sparing in participants with chronic radiculopathic pain syndromes maintained on opioid therapy. An Investigational New Drug (IND) application has been approved by the U.S. Food...

GREENWOOD, Colo. & NEW YORK, January 12, 2021 - ANANDA Scientific Inc., a biotech pharma company, and NYU Grossman School of Medicine today announced a new clinical trial evaluating the efficacy of cannabidiol in ANANDA’s proprietary delivery technology as a treatment for Post-Traumatic Stress Disorder (PTSD) symptoms and Neurocognitive Impairment in patients with PTSD and with PTSD comorbid with traumatic brain injury. An Investigational New Drug...

GREENWOOD, Colo., September 8, 2020 - ANANDA Scientific Inc., a biotech pharma company, today announced that Sohail Zaidi has been appointed as ANANDA’s new President. "Sohail Zaidi is already proving to be an extraordinary leader who has been flawlessly executing our pioneering clinical trial program, and we are thrilled to continue pursuing ANANDA’s strategic vision under his guidance," said Mark J. Rosenfeld, M.S., Ph.D., ANANDA Scientific’s Chief...

GREENWOOD, Colo., August 18, 2020 - ANANDA Scientific Inc., a biotech pharma company, today announced that John Suh, previously CEO of LegalZoom, has been appointed to ANANDA’s Board of Directors as its new Executive Director. "We are very pleased to welcome John as Executive Director of the ANANDA Board of Directors," said Mark J. Rosenfeld, M.S., Ph.D., ANANDA Scientific’s Chief Executive Officer. "John’s experience in growing successful...

GREENWOOD, Colo., April 1, 2020 (Newswire.com) - ANANDA Scientific, a biotech pharma company, today announced that its clinical research team will initiate trials to assess the company´s proprietary Liquid Structure™ Cannabidiol (CBD) formulation as a treatment for mitigating the impact of COVID-19 infections, specifically, the “cytokine storms” that result from an excessive production of immune system proteins and are a major cause of severe respiratory distress, other...

  GREENWOOD, Colo., March 17, 2020 (Newswire.com)   ANANDA Scientific, a clinical-stage biotech company pioneering patented delivery technologies for cannabinoids and other plant-derived compounds, today announced the launch of a new science-based breakthrough for effective delivery of CBD in beverages. This new water-stable formulation of ANANDA’s patented, high-bioavailability Liquid StructureTM CBD corrects many of the shortfalls of CBD beverage products currently on the market.   “ANANDA’s innovative patented delivery technology (United States...